Jason Ehrlich - Jun 11, 2022 Form 4 Insider Report for Kodiak Sciences Inc. (KOD)

Role
Chief Medical Officer and Chief Development Officer
Signature
/s/ David Peinsipp, Attorney-in-Fact for Jason Ehrlich
Stock symbol
KOD
Transactions as of
Jun 11, 2022
Transactions value $
$0
Form type
4
Date filed
6/14/2022, 08:32 PM
Previous filing
Feb 18, 2022
Next filing
Jun 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KOD Common Stock Options Exercise +2.9K +5.58% 54.9K Jun 11, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KOD Restricted Stock Units Options Exercise $0 -2.9K -33.33% $0.00 5.8K Jun 11, 2022 Common Stock 2.9K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock.
F2 Includes (i) 73 shares acquired under the 2018 Employee Stock Purchase Plan ("ESPP") on November 30, 2021 and (ii) 399 shares acquired under the ESPP on May 31, 2022.
F3 One-fourth (1/4th) of the RSUs vested on June 11, 2021, upon the achievement of certain performance criteria ("Performance Achievement Date"); thereafter, the RSUs will vest in three equal annual installments on each of the first, second, and third anniversaries of the Performance Achievement Date, subject, in each case, to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.

Remarks:

Chief Medical Officer and Chief Development Officer